Guardion Health Sciences, Inc.
GHSIDelisted Oct 11, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001642375
Guardion Health Sciences, Inc. was delisted on Oct 11, 2024; its insiders filed their last Form 4 on Aug 28, 2024; 15 institutions reported holding it in 13F filings for Q3 2024, worth $587.7K in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Guardion Health Sciences, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
GHSI is no longer listed, and 13F filings after Q3 2024 list far fewer holders. See Q3 2024
- Institutional holders
- 0
- −15 vs. Q3 2024
- Shares held
- 0
- −106.1K (−100.0%) vs. Q3 2024
- Total value
- $0
- −$587.7K (−100.0%) vs. Q3 2024
- New holders
- 0
- 0 more added
- Sold out
- 15
- 0 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHSI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 15 | $587.7K |
| Q2 2024 | 12 | $674.9K |
| Q1 2024 | 12 | $595.0K |
| Q4 2023 | 11 | $347.9K |
| Q3 2023 | 14 | $497.7K |
| Q2 2023 | 13 | $387.4K |
| Q1 2023 | 10 | $314.5K |
| Q4 2022 | 22 | $545.8K |
| Q3 2022 | 23 | $659.0K |
| Q2 2022 | 22 | $654.3K |
| Q1 2022 | 20 | $1.09M |
| Q4 2021 | 20 | $1.61M |
| Q3 2021 | 19 | $3.82M |
| Q2 2021 | 16 | $4.80M |
| Q1 2021 | 14 | $4.14M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Guardion Health Sciences, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −38,804−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −17,190−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −14,852−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −12,609−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,579−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −10,030−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −559−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −373−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |